Zetiq develops cancer diagnostic tools, positioned to target the high market value of cancer diagnostics. A huge medical need exists for early stage diagnostic tools that can be used for screening, monitoring or diagnosing cancer. With validated clinical data, Zetiq offers unique business advantages in this market with its proprietary CellDetect® technology for differential staining of cancer cells.
